Search

everythinglearnresearchcommunity

for

Search:↓

The document is a detailed medical reference on skin and genetic disorders.

Alopecia in patients with epidermolysis bullosa varies in severity and is often caused by skin blistering or trauma.

Different hair evaluation methods have their own pros and cons, and using multiple methods together is best for accurate hair loss diagnosis and tracking.

Epidermal growth factor helps hair recover after chemotherapy.

High levels of the seizure medication sodium valproate can cause hair loss.

Experts agreed on guidelines to improve research on Frontal Fibrosing Alopecia.

A woman and her daughter had thallium poisoning from a herbal drink and rodenticide, causing hair loss and other symptoms.

Alopecia Areata is an autoimmune condition causing hair loss, influenced by genetics, environment, and possibly improved by anti-MIF therapy, with many patients experiencing regrowth within a year.

Individualized Homeopathic Medicine shows promise for treating alopecia with lasting hair regrowth.

Lower vitamin D levels are linked to more severe alopecia areata.

Higher stress levels may worsen alopecia areata, suggesting stress management is important for treatment.

New treatments for skin conditions show promise, especially Coacillium® for hair growth in young people with alopecia areata.

Targeted therapy with Ustekinumab significantly improved a skin condition called ILVEN, which is caused by mutations in the CARD14 gene.

Platelet-rich plasma treatment significantly increased hair regrowth and decreased discomfort in alopecia patients, making it a potentially better and safer treatment option.

Certain mouse strains develop a skin condition similar to a human hair loss disease due to genetic defects.

A new CDH3 gene mutation was found in a Spanish patient with sparse hair and eye issues.

A new mutation in the PLEC gene causes a rare condition with skin blistering, muscle weakness, and hair loss.

Patients with chronic graft-versus-host disease often have skin problems like vitiligo and alopecia areata.

Certain factors like allergies, nail problems, and hair loss patterns can predict how well someone with patchy hair loss will respond to skin cream treatments.

A rare endocrine disorder, APS 1, was diagnosed in a 26-year-old man in Bangladesh.

Chemotherapy patients don't all lose their hair due to factors like hair growth rates, age, genetics, and the type of drugs used.

Topical PROTACs show promise for treating skin conditions but need better stability and delivery methods.

Antiviral drugs, especially daclatasvir, may be a new treatment for a rare skin disease, improving survival and reducing symptoms in mice.

Glucocorticoid corticosteroids improve muscle strength in Duchenne muscular dystrophy but can cause side effects.

ILC1 cells contribute to hair loss in alopecia areata.

Young rats are better for testing hair loss treatments after chemotherapy.

Natural products like propolis are causing more skin allergies, and certain skin treatments and medications have various side effects and risks.

People with late-stage HIV-1 often experience a specific type of hair loss linked to multiple factors, including nutritional issues and immune responses.

CRISPR gene editing reduces harmful molecules in cells from Emery–Dreifuss Muscular Dystrophy patients.

Ruxolitinib helped a woman with a genetic mutation regrow her hair and improved her health.